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Bacteriocine typing has been shown to be successful in the characterization of specific strains of several genera of Gram-negative bacilli. Such typing enabled Abbott and Shannon (1958) , Abbott and Graham (1961) , and Gillies (1964) to study outbreaks of dysentery caused by Shigella sonnei. Likewise a detailed study of the bacteriocines (pyocines) produced by Pseudomonas aeruginosa led to typing schemes based on pyocine production (Wahba, 1963; Darrell and Wahba, 1964 ; Gillies and Govan, 1966) . Linton (1960) described a method of colicine typing of strains of Escherichia coli. However, the production of bacteriocines (proteocines) by members of the genus Proteus has been little studied. An initial investigation into the typing of strains of Proteus by this method was unsatisfactory as only three proteocine types were discovered (Cradock-Watson, 1965) .
Nevertheless it has now been established that, by using liquid preparations of proteocines, a much more satisfactory typing scheme may be developed based on proteocine sensitivity.
Method and Materials

MEDIA
(a) PP3 broth-Difco Proteose-peptone No. 3, 20 g, and sodium chloride, 5 g, are dissolved in 10 litre distilled water, adjusted to pH 7-4, distributed in 5 ml amounts in test-tubes or in 50 ml amounts in 250 ml conical flasks, and autoclaved at 121°C for 15 minutes.
(b) Bile-salt-brain-heart infusion Agar-(BBHIA).
Brain-heart infusion powder (oxoid) 36 ing. Before use, 12 ml amounts of melted medium were distributed into sterile 9 cm diameter plastic Petri dishes, and the plates were dried in the incubator at 37°C for 2 hours.
SOURCE OF STRAINS
Five hundred and sixty-eight Proteus strains were obtained from clinical specimens from hospital patients during a period of nine months. The majority of organisms were isolated from urine and smaller numbers of pus, nasal, and wound swabs. Duplicate isolates from the same patients were avoided.
BIOCHEMICAL IDENTIFICATION
The conversion of phenylalanine to phenylpyruvic acid and the hydrolysis of urea on Christensen's medium were used as criteria to place non-lactosefermenting Gram-negative bacilli in the genus Proteus. Proteus mirabilis and Proteus vulgaris were identified on the basis of indole and H2S production, decarboxylation of ornithine, and fermentation of maltose. It was found that 59% were P. mirabilis and 41 % P. vulgaris.
PRODUCTION OF PROTEOCINE
For production of proteocines, isolates are inoculated into 5 ml amounts of PP3 broth and incubated at 25°C. After 18 hours this culture is added to 50 ml of pre-heated (25°C) PP3 broth and incubated with orbital shaking at 25°C. After one hour mitomycin C (55 ,ug) is added to each culture to give a final concentration of 1 Htg mitomycin C per ml and the incubation is continued for a further 24 hours. The broth cultures are centrifuged at 3000 rev/min for 20 minutes, and the supernatant fluid is transferred to fresh sterile containers. Chloroform, 0 5 ml, is added to each flask, the contents of which are then thoroughly agitated for 5 minutes. The cultures are then Bacteriocine typing ofProteus centrifuged again at 3000 rev/min for 20 minutes, and the chloroform-free sterilized proteocine preparation forms the supernatant which is finally removed to sterile screw-capped bottles and stored at 4°C until required. The proportion of bacteriocinogenic isolates is shown in Thus, in order to ensure as wide a spectrum of activity as possible, a representative isolate was selected from each of these 12 major groups and proteocine containing preparations were prepared from these. An indicator strain was selected for each of the 12 proteocine preparations These strains were particularly susceptible to the proteocine being tested. The 12 proteocine preparations were then decimally diluted in saline so that dilutions of up to 10-4 were obtained. Each dilution was spotted onto the same lawn of its particular organism, and the titre of each preparation was given as the reciprocal of the highest dilution showing complete inhibition of the indicator strain. Thus the neat preparations were standardized so that each had an in use titre of 104 with respect to its own indicator strain. These were used in the subsequent routine tests.
None of the 12 standard proteocine preparations has any effect on 100 isolates of E. coli.
DEVELOPMENT OF TYPING SYSTEM
The 12 standard proteocines were then used to type 1000 isolates of Proteus obtained during the routine examination of clinical specimens. These included isolates obtained repeatedly from the same sites of infection. To record the results the signs (+) and (-) were used. A (+) designated proteocine activity shown by either complete or partial inhibition, and a (-) indicated no inhibition. For example, 35 isolates gave the same result, with (+) reactions to preparations 4 and 5 only, which formed sensitivity pattern No. 1. All isolates were sensitive to at least one of the proteocine preparations and a total of 48 proteocinesensitivity patterns were demonstrated (table II) . These were arbitrarily numbered and each isolate was subsequently assigned to one of the numbered sensitivity patterns. Thus proteocine patterns 1 to 48 were designated and any individual isolate was described as belonging to a particular sensitivity pattern.
It is possible to simplify the description of the proteocine inhibition pattern by the introduction of a simple code. The 12 standard proteocine producers are divided into four lots of three, and each triplet is numbered (421, 421, etc.) ( 0600  0702  4012  4011  2602  0111  3004  3100  4100  5012  2102  0100  0700  4112  7000  4110  0440  0504  2106  3002  4600  5000  0121  0134  0010  0011  0004  0001  0040  0102  0120  0101  0602  0502  0442  1000  3402  2002  2100  5100  3102  3020  2702  2104  0542  1400  3104  0110   35  46  27  21  16  16  34  15  23  16  23  25  37  42  20  18  51  16  16  18  19  16  15  13  12  15  18  19  18  15  19  20  31  17  18  13  15  16  20  17  15  17  17  15  21  15  24 (b) Bacteriocine Sensitivity It must be demonstrated that the same organism displays an identical inhibition pattern when tested repeatedly against the same set of bacteriocine preparations and that organisms isolated from the same known source on several occasions also exhibit the same inhibition pattern on testing against the same set of bacteriocines. It was found that, in practice, no change in sensitivity patterns was detectable when the same isolate, stored on a nutrient agar slope, was re-tested over a period of months, nor was any change in sensitivity patterns demonstrated with organisms isolated on as many as 10 separate occasions from the same site of the same infected patient. No patient was found to excrete more than one strain of Proteus simultaneously.
(c) Standardization of the Indicator Inoculum As with antibiotic sensitivity testing, differences in the density of bacteria on the surface of the plate can cause apparent variations in the sensitivity of an organism to a bacteriocine preparation. The ability of the dilution method to give a standardized bacterial lawn was therefore checked by the method of Miles and Misra. It was found that the dilution used contained approximately 106 organisms per ml which gave almost confluent growth of the indicator organism.
(d) Specificity of the System The 48 different sensitivity patterns obtained showed a fairly uniform distribution of the 1000 isolates tested. The highest number of isolates in one pattern is 51, giving a percentage of 5-1 of the total. The lowest number of organisms falling into one sensitivity pattern is 12, which is 1'2 % of the total (table  II) . The specificity of the system is shown by this uniformity in the distribution of the 1000 strains.
In addition to the 1000 strains dealt with here, 204 isolates of epidemiological importance were also typed using this system and compared with other typing methods. The results appear in this issue (Al-Jumaili, 1975 ).
Discussion
The increase in Proteus infections in hospitals has made it desirable to develop a satisfactory method to 787 identify strains which may be responsible for crossinfection. Although serological methods were tried and met with a certain amount of success (Perch, 1948) , it has now been shown that bacteriocine typing methods can be used successfully as an epidemiological tool for use with Proteus. Previous attempts to bacteriocine or bacteriophage-type these organisms have been unsatisfactory (Cradock-Watson, 1965 . As bacteriocine typing provides a technically simple and reliable epidemiological method, it seems likelythat systems developed along the linesdescribed in this paper will eventually result in a simple and quick method of typing Proteus. Areas of further investigation include the possibility of improving the bacteriocine yield by varying media, cultural conditions, etc. (George, 1975) , the improved standardization of proteocine preparations by study of individual pure proteocines, and the extension of such systems to cover Proteus rettgeri, Proteus morgani, and possibly even Providencia isolates.
